Interestingly belimumab, an FDA-approved monoclonal antibody medication, is utilized in the management of specific autoimmune disorders, notably systemic lupus erythematosus (SLE) and lupus nephritis and operates by binding to and neutralizing BAFF [14, 15]. Here, TNFSF13B is linked to systemic lupus erythematosus.